Sort
39,280 grants matching “leukemia”
Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells
$658,812Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · DK
Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells
$658,812Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · DK
Eltombopag: Novel Mode of Action on Normal and Aplastic Anemia Hematopoietic Stem Cells
$658,812Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · DK
Novel targeted therapy for treating Ovarian Cancer
$658,621Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2025 · CA
Mechanisms and therapeutic implications of human clonal hematopoiesis (CH) mutations
$658,437Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Transition State Analysis of Enzymatic Reactions
$658,125Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2009 · GM
Implementation of an interventional, risk-adapted clinical trial for children with newly diagnosed juvenile myelomonocytic leukemia.
$658,014Elliot Stieglitz · University Of California, San Francisco · R37 · FY2023 · CA
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2022 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2023 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2025 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2024 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2021 · GM
Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison
$657,991Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
$657,865William E. Evans · St. Jude Children'S Research Hospital · R37 · FY2011 · CA
Collaborative Pathways that Lead to Leukemia
$657,818Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Novel Approaches to CD33-Directed Radioimmunotherapy
$657,666Roland Bruno Walter · Fred Hutchinson Cancer Center · R37 · FY2025 · CA
Project 1: Chromosome Inheritance
$657,623Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2020 · CA
Project 1: Chromosome Inheritance
$657,623Bruce W Stillman · Cold Spring Harbor Laboratory · P01 · FY2021 · CA
Conformal Total Body and Marrow Irradiation for Leukemia
$657,603Susanta K Hui · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Apolipoprotein M: a novel regulator of myocardial Autophagy
$657,555Ali Javaheri · Washington University · R01 · FY2021 · HL
Apobec3 and the Neutralizing Antibody Response Against Pathogenic Retroviruses
$657,523Mario Luis Santiago · University Of Colorado Denver · R56 · FY2009 · AI
Mechanisms of Leukemogenesis in AMKL
$657,473Diane S. Krause · Yale University · R01 · FY2024 · CA
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
$657,305Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
TCR engineered T cell therapies for hematologic malignancies
$657,016Kazusa Ishii · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
PHARMACOGENOMICS OF CHILDHOOD LEUKEMIA (ALL)
$656,917William E. Evans · St. Jude Children'S Research Hospital · R37 · FY2012 · CA